Alexion Pharmaceuticals Q2 2016 Earnings Call

Alexion Pharmaceuticals' second quarter 2016 earnings teleconference held on July 28, 2016, covering financial updates, commercial progress, and R&D developments. The presentation discusses financial results, commercialization efforts for products including Soliris®, Strensiq®, and Kanuma®, and clinical program updates across the company's pipeline.